|  Help  |  About  |  Contact Us

Publication : Glucose-Stimulated Insulin Secretion Fundamentally Requires H<sub>2</sub>O<sub>2</sub> Signaling by NADPH Oxidase 4.

First Author  Plecitá-Hlavatá L Year  2020
Journal  Diabetes Volume  69
Issue  7 Pages  1341-1354
PubMed ID  32245800 Mgi Jnum  J:293332
Mgi Id  MGI:6445929 Doi  10.2337/db19-1130
Citation  Plecita-Hlavata L, et al. (2020) Glucose-Stimulated Insulin Secretion Fundamentally Requires H2O2 Signaling by NADPH Oxidase 4. Diabetes 69(7):1341-1354
abstractText  NADPH facilitates glucose-stimulated insulin secretion (GSIS) in pancreatic islets (PIs) of beta-cells through an as yet unknown mechanism. We found NADPH oxidase isoform 4 (NOX4) to be the main producer of cytosolic H2O2, which is essential for GSIS; an increase in ATP alone was insufficient for GSIS. The fast GSIS phase was absent from PIs from NOX4-null, beta-cell-specific knockout mice (NOX4betaKO) (though not from NOX2 knockout mice) and from NOX4-silenced or catalase-overexpressing INS-1E cells. Lentiviral NOX4 overexpression or H2O2 rescued GSIS in PIs from NOX4betaKO mice. NOX4 silencing suppressed Ca(2+) oscillations, and the patch-clamped KATP channel opened more frequently when glucose was high. Mitochondrial H2O2, decreasing upon GSIS, provided alternative redox signaling when 2-oxo-isocaproate or fatty acid oxidation formed superoxides through electron-transfer flavoprotein:Q-oxidoreductase. Unlike GSIS, such insulin secretion was blocked with mitochondrial antioxidant SkQ1. Both NOX4 knockout and NOX4betaKO mice exhibited impaired glucose tolerance and peripheral insulin resistance. Thus, the redox signaling previously suggested to cause beta-cells to self-check hypothetically induces insulin resistance when it is absent. In conclusion, increases in ATP and H2O2 constitute an essential signal that switches on insulin exocytosis for glucose and branched-chain oxoacids as secretagogues (it does so partially for fatty acids). Redox signaling could be impaired by cytosolic antioxidants; hence, those targeting mitochondria should be preferred for clinical applications to treat (pre)diabetes at any stage.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

12 Bio Entities

Trail: Publication

0 Expression